Viewing Study NCT05536804


Ignite Creation Date: 2025-12-24 @ 7:50 PM
Ignite Modification Date: 2025-12-28 @ 3:36 PM
Study NCT ID: NCT05536804
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-29
First Post: 2022-09-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module